Land: Irland
Språk: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
NAPROXEN
Aziende Chimiche Riunite Angelini Francesco
M02AA12
NAPROXEN
10 %w/w
Gel
Product subject to prescription which may be renewed (B)
Propionic acid derivatives
Authorised
2010-04-23
NAPROXEN 10%W/W gel MODULE 1.3.1 – SPC, LABELLING AND PACKAGE LEAFLET PAGE 1 PACKAGE LEAFLET: INFORMATION FOR THE USER MOMENDOL 10% W/W GEL NAPROXEN READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What MOMENDOL GEL is and what it is used for 2. What you need to know before you take MOMENDOL GEL 3. How to take MOMENDOL GEL 4. Possible side effects 5. How to store MOMENDOL GEL 6. Contents of the pack and other information 1. WHAT MOMENDOL IS AND WHAT IT IS USED FOR MOMENDOL gel belongs to the class of non-steroidal analgesic-antiinflammatory drugs for topical use. Momendol gel is used locally to treat muscular and arthicular pain such: muscle pain (myalgia), lumbar pain, stiff neck, inflammation of bursa near a joint or tendon (bursitis), inflammation of tendons (tendinitis), inflammation of synovia surrounding tendons (tenosynovitis), inflammation around a joint (periarthritis), strained muscles, contusions and hematoma. Momendol may be used as an adjuva Les hele dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT MOMENDOL 10% w/w GEL 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 g contains 100 mg naproxen (10% w/w). For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Gel. Transparent, homogeneous and from colourless to slightly yellow and slightly sweet-smelling gel. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Momendol 10% gel is indicated in adults and children above 12 years for topical treatment of pain in musculoskeletal disorders such as myalgia, backache, stiff neck, bursitis, tendinitis, tenosynovitis, periarthritis, muscular sprains, contusions, hematoma. Coadjuvant to orthopaedic and rehabilitation therapies. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY Spread Momendol Gel 10% on the painful area two times daily. Maximum duration of use should not exceed 7 days. PAEDIATRIC POPULATION Momendol 10% gel is not recommended for use in children below 12 years. The safety and efficacy of Momendol Gel 10% in children under 12 years have not yet been established. No data are available. METHOD OF ADMINISTRATION Spread Momendol Gel 10% on the painful area and lightly massage to complete absorption. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance or any of the excipients listed in section 6.1. Third trimester of pregnancy. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Avoid using the gel on eyes, mucous membranes, wounds and/or skin lesions. Blood concentrations reached by active substance absorbed through the skin are not such as to expose to risks of undesirable effects or make warnings concerning the systemic administration of the drug applicable. However, use of Momendol Gel 10% is not recommended in patients presenting allergic reactions to acetylsalicylic HEALTH PRODUCTS REGULATO Les hele dokumentet